Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Brief SEE FAR CBT: a short, focused therapy for adults with PTSD

Official title: A Clinical Study Evaluating the Effects of a Brief SEE FAR CBT Intervention Compared With Dynamic Psychotherapy Treatment as Usual on Psychological Outcomes in Adults With Posttraumatic Stress Disorder

Run by Community Stress Prevention Center · NCT07710573 · Data updated 2026-11-12

A 6-session Brief SEE FAR CBT treatment is tested against usual dynamic psychotherapy for adults with PTSD to see if it reduces symptoms.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorCommunity Stress Prevention Center
Academic / other
Locations1 site (Sha'ar Hanegev)
StatusRecruiting
StartedJuly 2026
Main results expectedDecember 2027
Study endsMarch 2028
Registry record updatedJuly 17, 2026
Trial IDNCT07710573 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 and older with PTSD symptoms (PCL-5 score 30-60), Hebrew-speaking, able to consent, and willing to participate in the assigned intervention.

Probably not a fit

Individuals with PTSD outside the defined PCL-5 range or who cannot commit to the assessment schedule may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares a newly developed Brief SEE FAR CBT protocol to dynamic psychotherapy as the standard care for adults with PTSD. Participants receive six brief sessions targeting intrusive symptoms and then continue the full SEE FAR CBT program. Outcomes are measured with self-report questionnaires at baseline, after 6 and 12 sessions, and at a 3-month follow-up, focusing on PTSD symptoms as well as anxiety, depression, stress, resilience, somatic symptoms, and sleep. The study aims to determine whether the Brief SEE FAR CBT approach improves psychological outcomes compared with usual care.

Why it matters

Potential benefit: If successful, participants may experience greater reductions in PTSD symptoms and related distress with a shorter, focused treatment.

How similar studies have gone: Previous studies have shown promise for SEE FAR CBT approaches, but the brief version is a relatively novel approach that requires confirmation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

Participants must meet all of the following criteria:

* Age 18 years or older
* PTSD symptoms, defined as a PCL-5 score of 30-60
* Hebrew-speaking
* Able to provide informed consent
* Willing and able to participate in the assigned psychological intervention and complete study questionnaires at baseline, after 6 sessions, after 12 sessions, and at 3-month follow-up Exclusion Criteria

Participants will be excluded if they meet any of the following criteria:

* Pregnancy at the time of enrollment, due to the potential influence of pregnancy and childbirth during the treatment or follow-up period on psychological outcomes
* Currently receiving psychotherapy of any type that began less than 3 months prior to enrollment
* Initiation of psychiatric medication less than 3 months prior to enrollment

Where it's running

  • The Center for Psychological Services Sha'ar Hanegev
    Sha'ar Hanegev, Israel
    Recruiting

Study contacts

  • Principal investigator: Meital Mashash, PhD — Community Stress Prevention Center
  • Study coordinator: Meital Mashash, PhD
  • Email: meitalm@icspc.org
  • Phone: 972-50-2888052

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Anger, Social Thinking, and PTSD in French Veterans

    This study tests whether PTSD in former French military personnel is linked to higher anger through changes in social thinking abilities.

    Recruiting Direction Centrale du Service de Santé des Armées · Draguignan · NCT07851090

  • TSND-201 treatment for PTSD in adults

    This study tests two doses of TSND-201 or placebo to see if it helps adults with PTSD.

    Recruiting at 9 sites Phase 3 Transcend Therapeutics · Denver, Colorado and 8 other locations · NCT07836647

  • Long-term outcomes after Hyperbaric Oxygen Therapy in veterans with TBI, PCS, or PTSD

    This study tests whether benefits from HBOT persist over time for veterans with brain injury or related conditions.

    Recruiting Phase 2 Summit Hyperbarics and Wellness · Boise, Idaho · NCT07732374

  • SEE FAR CBT for Adults With PTSD

    This 12-week, one-on-one SEE FAR CBT program tests a trauma-focused therapy to see if PTSD symptoms improve in adults 18 and older.

    Recruiting Community Stress Prevention Center · Kiryat Shmona · NCT07720674

  • MDMA Therapy for PTSD in Veterans

    This phase 2 study tests a fixed 120 mg dose of MDMA, followed by a 60 mg supplemental dose, plus therapy, to see if it helps adults who are veterans with PTSD.

    Recruiting Phase 2 Sunstone Medical · Rockville, Maryland · NCT07569159

  • Predicting childbirth PTSD after unplanned cesarean using early postpartum screening

    This study tests whether brief postpartum questionnaires taken 24-48 hours after delivery can predict childbirth-related PTSD symptoms at 6 weeks in people who had an unplanned cesarean.

    Recruiting University of British Columbia · Vancouver, British Columbia · NCT07561632

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.